Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K032997
    Date Cleared
    2003-10-15

    (20 days)

    Product Code
    Regulation Number
    870.1435
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The HORIZON 9000 WS (Cathlab) is a state-of-the-art computerized laboratory, capable of acquiring and displaying essential patient data such as ECG/Heart Rate, invasive blood pressure, pulse oximetry, respiration, cardiac output and body temperature. Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats.

    Device Description

    The Cathlab is capable of acquiring and displaying essential patient data such as ECG/Heart Rate, invasive blood pressure, pulse oximetry, respiration, cardiac output and body temperature. Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats. The Cathlab runs on a UNIX/Sun Solaris* operating system on a SUN® computer that utilizes spowerful, real-time software to control the system operation and to process the vital patient sign data measurements acquired from the Physiological Front End or entered manually at the keyboard. The Thermal Array Chart Recorder provides a continuous recording of all monitored vital signs, patient ID, time and date during the procedures. A Laser Printer is provided in addition to the Chart Recorder in the central console. This provides printouts of textual and graphical summaries of all patient data and catheterization procedures.

    AI/ML Overview

    This document describes a Special 510(k) for a device modification of the Horizon 9000WS Cathlab, specifically replacing the Patient Front End (PFE) with a Cathlab Front End (CFE). The submission aims to demonstrate that the modified device is substantially equivalent to the predicate device.

    Here's an analysis of the provided text, focusing on acceptance criteria and supporting studies:

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are not explicitly stated as "acceptance criteria" but are embedded within the product specifications for the Cathlab Front End (CFE). The device performance is reported as meeting these specifications.

    ParameterAcceptance Criteria (CFE Specification)Reported Device Performance
    Input Circuit Parameters
    Chassis Leakage Current< 50 µA, Meets or exceeds ANSI standard: "Safe Current Limits for Electromedical Apparatus," (SCLE) Dec, 1978 item 2.1.1.< 50 µA, Meets or exceeds ANSI standard: "Safe Current Limits for Electromedical Apparatus," (SCLE) Dec, 1978 item 2.1.1.
    ECG
    Frequency Response (Monitor)0.5 to 40 Hz0.5 to 40 Hz
    Frequency Response (Diagnostic)0.05 to 150 Hz, -3 dB0.05 to 150 Hz, -3 dB
    Frequency Response (Exercise)1 to 25 Hz, -3 dB1 to 25 Hz, -3 dB
    Input ImpedanceTypical 20 MΩ; Min > 5 MΩ differential (DC to 10 Hz); 2.5 MΩ differential (10 to 100 Hz); 3 MΩ differential (at 10 Hz)Typical 20 MΩ; Min > 5 MΩ differential (DC to 10 Hz); 2.5 MΩ differential (10 to 100 Hz); 3 MΩ differential (at 10 Hz)
    Common Mode RejectionAt least 100 dB at 50/60 Hz (Without lead misbalance); 86 dB (with lead misbalance); In accordance with ANSI/AAMI EC11 (9) Para. 3.2.14.At least 100 dB at 50/60 Hz (Without lead misbalance); 86 dB (with lead misbalance); In accordance with ANSI/AAMI EC11 (9) Para. 3.2.14.
    Input Dynamic Range±5mV p-p at a rate up to 320mV/sec, as per ANSI/AAMI EC13(8) Para. 3.2.9.1.±5mV p-p at a rate up to 320mV/sec, as per ANSI/AAMI EC13(8) Para. 3.2.9.1.
    Input Offset± 300mV, as per ANSI/AAMI EC13 Para. 3.2.9.1.± 300mV, as per ANSI/AAMI EC13 Para. 3.2.9.1.
    NoiseLess than 30 μ V p-p referenced to inputLess than 30 μ V p-p referenced to input
    Pacemaker Pulse RejectionReject pulses from 2.0 mV to 700 mV with 0.2 to 2.0 mSec pulse widths and ≥3.0mV for 0.1mSec pulse widthReject pulses from 2.0 mV to 700 mV with 0.2 to 2.0 mSec pulse widths and ≥3.0mV for 0.1mSec pulse width
    Defibrillator ProtectionUp to 5 KV. Amplifier Recovery time: < 3 secondsUp to 5 KV. Amplifier Recovery time: < 3 seconds
    QRS Detection0.25 to 5.0 mV, 70-120 msec width0.25 to 5.0 mV, 70-120 msec width
    Synchronous Defibrillation SignalPulse Width: 100 ms; Amplitude: 5 Vdc into 500Ω, short-circuit proofPulse Width: 100 ms; Amplitude: 5 Vdc into 500Ω, short-circuit proof
    ECG Analog Output1 Volt / mVolt1 Volt / mVolt
    Heart Rate
    Range20 to 350 bpm20 to 350 bpm
    AccuracyWithin 2 bpmWithin 2 bpm
    Response TimeLess than 7 sec for step change of 60 bpm from a base of 60 bpmLess than 7 sec for step change of 60 bpm from a base of 60 bpm
    Blood Pressure
    Input Sensitivity5 μvolts/volt/mmHg5 μvolts/volt/mmHg
    Transducer Excitation5 Volt5 Volt
    Ranges-50 to +300 mmHg-50 to +300 mmHg
    Max Variation during Zero± 2 mmHg± 2 mmHg
    Zero Accuracy± 0.2 mmHg± 0.2 mmHg
    Zero DriftLess than +/- 0.2 mmHg in 24 hoursLess than +/- 0.2 mmHg in 24 hours
    Transducer Load Impedance300 – 600Ω300 – 600Ω
    LinearityBetter than 1% of full scaleBetter than 1% of full scale
    Common Mode Rejection80 dB minimum (reference to chassis 50/60Hz)80 dB minimum (reference to chassis 50/60Hz)
    Frequency ResponseDC to 12 Hz (DC to 40 Hz optional)DC to 12 Hz (DC to 40 Hz optional)
    Cardiac Output
    Range0.5 to 20 liter/minute0.5 to 20 liter/minute
    Frequency ResponseDC to 15 HzDC to 15 Hz
    Blood Temperature Range27 °C to 45°C27 °C to 45°C
    Injectate Temperature Range0°C to 25°C. (32°F to 77°F)0°C to 25°C. (32°F to 77°F)
    AccuracyBlood Temp ± 0.05°C; Inj. Temp ± 0.2 °CBlood Temp ± 0.05°C; Inj. Temp ± 0.2 °C
    LinearityBetter than 1% of full scaleBetter than 1% of full scale
    Temperature
    Range27 °C to 45°C27 °C to 45°C
    Accuracy± 0.2°C± 0.2°C
    Respiration
    Frequency Response0.13 to 2.5 Hz., 3 dB bandwidth0.13 to 2.5 Hz., 3 dB bandwidth
    Range8 to 150 bpm8 to 150 bpm
    Excitation65 kHz65 kHz
    Pulse Oximetry (SpO2)
    Probe TypeMasimo™ reusable or disposableMasimo™ reusable or disposable
    Range0% to 100%0% to 100%
    Pulse Rate Range20-250 bpm, below 20 displays zero20-250 bpm, below 20 displays zero
    Rate Accuracy± 3 bpm± 3 bpm
    SpO2 Accuracy (Adult)±2 digits between 70% and 100%; ±3 digits between 50% and 70%±2 digits between 70% and 100%; ±3 digits between 50% and 70%
    SpO2 Accuracy (Neonatal)±3 digits between 70% and 95%±3 digits between 70% and 95%
    Auxiliary Inputs
    Input Voltage+/-5 Volt+/-5 Volt
    Frequency ResponseDC to 120 HzDC to 120 Hz
    Non-Invasive Blood Pressure (NIBP)
    MethodOscillometricOscillometric
    Initial Inflation150 mmHg (adult); 120 mmHg (pediatric)150 mmHg (adult); 120 mmHg (pediatric)
    Pressure AccuracyOverall ± 3 mmHg, full scaleOverall ± 3 mmHg, full scale
    Defib. Pulse Protection5KV as per ANSI/AAMI EC13 (9), clause 3.2.2.2 and per IEC 60601-2-27 (12), clauses 17, 101 and 1025KV as per ANSI/AAMI EC13 (9), clause 3.2.2.2 and per IEC 60601-2-27 (12), clauses 17, 101 and 102
    Degree of protection against electrical shockType CF and BF (ECG, IBP and CO = CF; NIBP and SpO2 = BF)Type CF and BF (ECG, IBP and CO = CF; NIBP and SpO2 = BF)
    Electrosurgical Interference SuppressionYesYes

    2. Sample size used for the test set and the data provenance

    The document does not specify a separate "test set" in the context of image-based AI or diagnostic algorithm evaluation. Instead, it states that "The Cathlab with the CFE has been subject to extensive safety and performance testing to ensure that the signals/waveforms sent by the CFE to the Cathlab have the same characteristics as those sent by the PFE to the Cathlab." This implies a comparative testing approach rather than a traditional test set for an algorithm.

    The data provenance is not explicitly detailed. It can be inferred that the testing was performed by "Mennen Medical Ltd." (Israel) and an "independent testing laboratory" for electrical safety and EMC. There's no mention of country of origin of data in terms of patient population or images, as this is a physiological monitoring device rather than an imaging or diagnostic device. The testing describes the performance characteristics of the hardware and software, not historical patient data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. This device is a physiological monitor, not an AI or imaging diagnostic device that would require expert-established ground truth for a test set. The "ground truth" here is adherence to technical specifications and industry standards.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

    Not applicable, as there is no specific "test set" for diagnostic accuracy with human-expert adjudication in this context. The adjudication method for meeting technical standards would typically involve verification by qualified engineers/testers against established metrics.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This document pertains to a hardware modification for a physiological monitoring device and does not involve AI for interpretation or improvement of human reader performance.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    Not applicable. This device is a physiological monitor; its performance is described in terms of its ability to acquire and display patient data, not as a standalone diagnostic algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" used for this device modification is based on technical specifications, industry standards (e.g., ANSI/AAMI, IEC), and the performance characteristics of the predicate device (Horizon 9000WS Cathlab with PFE). The goal was to ensure the modified CFE matched or exceeded the performance of the existing PFE.

    8. The sample size for the training set

    Not applicable. This document describes a hardware device modification, not a machine learning model that would require a training set.

    9. How the ground truth for the training set was established

    Not applicable, as there is no training set for a machine learning model described.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1